US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

595.68

+3.690.62%

Post-market: 598.102.42+0.41%17:09 EDT

Volume:904.73K

Turnover:539.07M

Market Cap:63.13B

PE:15.01

High:600.75

Open:593.00

Low:588.67

Close:591.99

52wk High:1,154.56

52wk Low:476.49

Shares:105.99M

Float Shares:103.30M

Volume Ratio:0.75

T/O Rate:0.88%

Dividend:2.64

Dividend Rate:0.44%

EPS(TTM):39.67

EPS(LYR):40.90

ROE:15.34%

ROA:6.66%

PB:2.11

PE(LYR):14.57

Loading ...

Overview Company News Filings

Sanofi Sees Progress for Hives Treatment in EU, Longer U.S. Review for MS Drug

CommuniquÉ De Presse : Sanofi Et Regeneron Voient L’autorisation Du Dupixent Pour Le Traitement De L’urticaire Chronique SpontanÉE Progresser Dans L’ue GrÂCe À Un Avis Positif Du Chmp

THOMSON REUTERS

Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion

Regeneron Pharmaceuticals Inc - to Donate 500 Doses of Inmazeb to Who

THOMSON REUTERS

Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Regeneron's Potential Obesity Treatment Could Preserve Muscle Mass

Regeneron Pharmaceuticals Shares up 1.4% After Rare Bone Disorder Drug Succeeds in Late-Stage Trial

THOMSON REUTERS

Regeneron announces updated analyses from Phase 2 COURAGE trial

Results From Phase 2 Courage Trial Demonstrating Potential to Improve Quality of Glp-1 Receptor Agonist-Induced Weight Loss by Preserving Lean Mass, Presented at Easd

THOMSON REUTERS

Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint

MT Newswires Live

Regeneron announces primary endpoint met in Phase 3 OPTIMA trial

Regeneron Pharmaceuticals Inc - Garetosmab Shows 90% Reduction in New Ho Lesions

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - U.S. Regulatory Submission for Garetosmab Planned for Year-End 2025

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - Announces Primary Endpoint Met in Phase 3 Fop Trial

THOMSON REUTERS

Regeneron Pharmaceuticals Inc - Garetosmab Shows 94% and 90% Reduction in New Bone Lesions

THOMSON REUTERS

Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Does Regeneron Offer Value After Shares Slide 21.7% Year to Date in 2025?

Simply Wall St.

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/REGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":595.68,"timestamp":1758571200000,"preClose":591.99,"halted":0,"volume":904732,"hourTrading":{"tag":"盘后","latestPrice":598.1,"preClose":595.68,"latestTime":"17:09 EDT","volume":117646,"amount":70081609.25984,"timestamp":1758575387677},"delay":0,"floatShares":103302739,"shares":105987442,"eps":39.673737,"marketStatus":"Post-Mkt","change":3.69,"latestTime":"09-22 17:17:21 EDT","open":593,"high":600.75,"low":588.6734,"amount":539073343.5231999,"amplitude":0.0204,"askPrice":600.1,"askSize":10,"bidPrice":598.1,"bidSize":89,"shortable":3,"etf":0,"ttmEps":39.673737,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1758585600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":591.99,"dividendRate":0.004432,"preHourTrading":{"tag":"盘前","latestPrice":593,"preClose":591.99,"latestTime":"09:23 EDT","volume":309,"amount":183508.31745,"timestamp":1758547438874},"postHourTrading":{"tag":"盘后","latestPrice":598.1,"preClose":595.68,"latestTime":"17:09 EDT","volume":117646,"amount":70081609.25984,"timestamp":1758575387677},"volumeRatio":0.745142,"impliedVol":0.3588,"impliedVolPercentile":0.4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":103302739,"roa":"6.66%","roe":"15.34%","lyrEps":40.895273,"volumeRatio":0.745142,"shares":105987442,"dividePrice":2.64,"high":600.75,"amplitude":0.0204,"preClose":591.99,"low":588.6734,"week52Low":476.4869,"pbRate":"2.11","psRate":"4.44","week52High":1154.56,"institutionHeld":0.8514,"latestPrice":595.68,"committee":0.79798,"eps":39.673737,"divideRate":0.004432,"volume":904732,"delay":0,"ttmEps":39.673737,"open":593,"prevYearClose":712.33,"prevWeekClose":591.99,"prevMonthClose":580.7,"prevQuarterClose":525,"fiveDayClose":572.59,"twentyDayClose":589.48,"sixtyDayClose":521},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"REGN","amount":0.88,"announcedDate":"2025-08-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-18","defaultRemindTime":1755523800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-03","payableDate":"2025-08-18","currency":"USD","dateTimestamp":1755489600000,"payDate":"2025-09-03"},{"market":"US","date":"2025-08-01","symbol":"REGN","fiscalQuarterEnding":"2025/06","expectedEps":6.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"pre","actualEps":10.72},{"date":"2025-05-20","symbol":"REGN","amount":0.88,"announcedDate":"2025-04-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-20","defaultRemindTime":1747747800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-06","payableDate":"2025-05-20","currency":"USD","dateTimestamp":1747713600000,"payDate":"2025-06-06"},{"market":"US","date":"2025-04-29","symbol":"REGN","fiscalQuarterEnding":"2025/03","expectedEps":6.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":6.43},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"},{"executeDate":"2025-05-20","recordDate":"2025-05-20","paymentDate":"2025-06-06","value":0.88,"currency":"USD"},{"executeDate":"2025-08-18","recordDate":"2025-08-18","paymentDate":"2025-09-03","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.5,"hold":0.1786,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":28,"updateTime":1756872000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-09-19","current":13.923363,"percent":0.371847,"low":7.447139,"twenty":11.200433,"median":15.184019,"eighty":20.660944,"high":30.763504,"avg":16.540037,"sd":5.762511,"marketCap":62078708399},"quantilePoints":[{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-17","current":13.322422,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"marketCap":58786517328},{"date":"2025-04-25","current":14.54678,"twenty":11.205526,"median":16.999149,"eighty":24.304801,"marketCap":64189123276},{"date":"2025-05-02","current":13.856076,"twenty":11.205526,"median":16.947475,"eighty":24.14557,"marketCap":62342643230},{"date":"2025-05-09","current":12.861961,"twenty":11.205526,"median":16.904119,"eighty":24.034457,"marketCap":57869822741},{"date":"2025-05-16","current":13.738417,"twenty":11.205526,"median":16.818894,"eighty":23.30219,"marketCap":61813259090},{"date":"2025-05-23","current":14.016947,"twenty":11.205526,"median":16.720573,"eighty":23.015778,"marketCap":63066451884},{"date":"2025-05-30","current":14.217508,"twenty":11.205526,"median":16.67877,"eighty":22.627279,"marketCap":63968835228},{"date":"2025-06-06","current":11.344838,"twenty":11.205526,"median":16.611067,"eighty":22.386399,"marketCap":51043831635},{"date":"2025-06-13","current":12.255347,"twenty":11.205526,"median":16.566176,"eighty":22.027357,"marketCap":55140482954},{"date":"2025-06-20","current":12.061362,"twenty":11.200433,"median":16.515091,"eighty":21.897066,"marketCap":54267685949},{"date":"2025-06-27","current":12.23562,"twenty":11.200433,"median":16.466434,"eighty":21.777356,"marketCap":55051723937},{"date":"2025-07-03","current":12.854681,"twenty":11.200433,"median":16.436479,"eighty":21.694973,"marketCap":57837066437},{"date":"2025-07-11","current":13.145893,"twenty":11.200433,"median":16.352502,"eighty":21.545896,"marketCap":59147318600},{"date":"2025-07-18","current":12.916681,"twenty":11.200433,"median":16.266005,"eighty":21.394057,"marketCap":58116023350},{"date":"2025-07-25","current":13.2605,"twenty":11.200433,"median":16.171129,"eighty":21.327342,"marketCap":59662966226},{"date":"2025-08-01","current":12.570256,"twenty":11.200433,"median":16.134227,"eighty":21.266838,"marketCap":56557352113},{"date":"2025-08-08","current":13.018488,"twenty":11.200433,"median":16.064063,"eighty":21.218674,"marketCap":58044230031},{"date":"2025-08-15","current":13.161975,"twenty":11.200433,"median":16.006911,"eighty":21.149835,"marketCap":58683981548},{"date":"2025-08-22","current":13.910573,"twenty":11.200433,"median":15.875495,"eighty":20.876399,"marketCap":62021680306},{"date":"2025-08-29","current":13.479181,"twenty":11.200433,"median":15.719991,"eighty":20.710997,"marketCap":60098278257},{"date":"2025-09-05","current":13.191044,"twenty":11.195339,"median":15.458743,"eighty":20.662336,"marketCap":58813590851},{"date":"2025-09-12","current":13.213835,"twenty":11.200433,"median":15.311559,"eighty":20.660944,"marketCap":58915204544},{"date":"2025-09-19","current":13.923363,"twenty":11.200433,"median":15.184019,"eighty":20.660944,"marketCap":62078708399}],"updateTime":1758547076621},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2569206909","title":"Sanofi Sees Progress for Hives Treatment in EU, Longer U.S. Review for MS Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2569206909","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569206909?lang=en_us&edition=fundamental","pubTime":"2025-09-22 14:46","pubTimestamp":1758523560,"startTime":"0","endTime":"0","summary":"France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended its review of its multiple sclerosis treatment.The European Medicines Agency's Committee for Medicinal Products for Human Use gave a positive recommendation for Dupixent to treat chronic spontaneous urticaria in adults and adolescents, Sanofi and Regeneron said Monday. The recommendation is based on results of late-stage studies showing Dupixent significantly reduced itch and hives at 24 weeks compared with a placebo, they said.If approved, Dupixent would become the first targeted chronic hives treatment available in the EU in more than a decade, the pharmaceutical companies said. The drug is already approved for this indication in the U.S., Japan, and other select countries.Meanwhile, Sanofi said the U.S. FDA extended by three months its review of its tolebrutinib treatment for non-relapsi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNYNF","IE00BZ1G4Q59.USD","LU0114720955.EUR","REGN","LU2362541273.HKD","IE00BKVL7J92.USD","LU1732800096.USD","LU0912757837.SGD","SNY","LU0158827781.USD","BK4097","LU0006306889.USD","BK4588","LU0267386448.USD","LU1732799900.SGD","BK4581","LU2347655156.SGD","BK4534","LU2237438978.USD","LU1244550221.USD","LU0823434583.USD","BK4156","LU1548497426.USD","BK4007","LU0320765992.SGD","BK4516","LU1720051108.HKD","LU1917777945.USD","LU0109394709.USD","LU2089283258.USD","LU0289739699.SGD","LU2089284900.SGD","LU0882574055.USD","PRGS","LU1989772923.USD","BK4127","LU2106854487.HKD","LU0106831901.USD","LU0314104364.USD","LU0225283273.USD","LU0882574139.USD","IE00BFXG1179.USD","LU1363072403.SGD","LU0823434740.USD","LU2023250504.SGD","LU0823416689.USD","LU1244550577.SGD","BK4585","LU1244550494.USD"],"gpt_icon":0},{"id":"2569083592","title":"CommuniquÉ De Presse : Sanofi Et Regeneron Voient L’autorisation Du Dupixent Pour Le Traitement De L’urticaire Chronique SpontanÉE Progresser Dans L’ue GrÂCe À Un Avis Positif Du Chmp","url":"https://stock-news.laohu8.com/highlight/detail?id=2569083592","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569083592?lang=en_us&edition=fundamental","pubTime":"2025-09-22 12:30","pubTimestamp":1758515400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250922:nTUA14GHSS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0882574055.USD","BK4588","LU2362541513.USD","LU2362540622.SGD","BK4585","LU0058720904.USD","LU0289739699.SGD","REGN","LU0320765992.SGD","LU0889565916.HKD","LU2023250504.SGD","LU1974910355.USD","LU0823416689.USD","LU0053666078.USD","LU0823434740.USD","LU0109394709.USD","LU2106854487.HKD","LU2237438978.USD","BK4139","LU0114720955.EUR","LU1917777945.USD","LU2089984988.USD","LU2362541273.HKD","LU0823434583.USD"],"gpt_icon":0},{"id":"2569082062","title":"Dupixent® (dupilumab) to Treat Chronic Spontaneous Urticaria (CSU) Advances in EU with Positive CHMP Opinion","url":"https://stock-news.laohu8.com/highlight/detail?id=2569082062","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569082062?lang=en_us&edition=fundamental","pubTime":"2025-09-22 12:29","pubTimestamp":1758515340,"startTime":"0","endTime":"0","summary":"Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo If approved, Dupixent would be the first targete","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/22/3153615/0/en/Dupixent-dupilumab-to-Treat-Chronic-Spontaneous-Urticaria-CSU-Advances-in-EU-with-Positive-CHMP-Opinion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4087","CHMP","LU0320765992.SGD","LU2362540622.SGD","LU2089984988.USD","REGN","LU0162691827.USD","LU2106854487.HKD","BK4096","LU1162221912.USD","LU2362541273.HKD","LU0053666078.USD","LU0882574055.USD","BK4139","LU0320765646.SGD","LU0823434583.USD","LU0114720955.EUR","LU0109394709.USD","LU0823434740.USD","LU0823416689.USD","BK4201","LU0058720904.USD","LU0289739699.SGD","LU1974910355.USD","BP","BK4588","PN","LU2362541513.USD","BK4007","BK4585","LU0889565916.HKD","LU1917777945.USD","SNY","BK4156","IE00BFXG1179.USD","LU1829250122.USD","LU0072461881.USD","LU2023250504.SGD","LU2468319806.SGD","LU2237438978.USD"],"gpt_icon":0},{"id":"2568252027","title":"Regeneron Pharmaceuticals Inc - to Donate 500 Doses of Inmazeb to Who","url":"https://stock-news.laohu8.com/highlight/detail?id=2568252027","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568252027?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:00","pubTimestamp":1758279636,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nFWN3V60VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","REGN","LU0889565916.HKD","LU2106854487.HKD","BK4588","LU2362541273.HKD","LU0882574055.USD","LU0109394709.USD","LU2089984988.USD","LU0823434583.USD","LU2023250504.SGD","LU0053666078.USD","LU0289739699.SGD","LU2237438978.USD","LU1974910355.USD","LU0320765992.SGD","LU0114720955.EUR","LU1917777945.USD","LU2362540622.SGD","LU2468319806.SGD","LU0058720904.USD","LU2362541513.USD","LU0823434740.USD","LU0823416689.USD","BK4139"],"gpt_icon":0},{"id":"2568369257","title":"Regeneron Donates Ebola Treatment for Use in Countries Most at Risk of Outbreaks","url":"https://stock-news.laohu8.com/highlight/detail?id=2568369257","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568369257?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:00","pubTimestamp":1758279600,"startTime":"0","endTime":"0","summary":"Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by theU.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense, also known as Zaireebolavirus Supply","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/19/3153073/0/en/Regeneron-Donates-Ebola-Treatment-for-Use-in-Countries-Most-at-Risk-of-Outbreaks.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4009","LU0882574055.USD","LU2023250504.SGD","LU0823434740.USD","LU2237438978.USD","LU0320765992.SGD","LU0053666078.USD","LU2362540622.SGD","LU1974910355.USD","LU0889565916.HKD","LU1917777945.USD","LU2468319806.SGD","LU0823434583.USD","BK4585","LU2362541513.USD","LU0109394709.USD","BK4139","LU0823416689.USD","BK4588","LU0114720955.EUR","LU0058720904.USD","LU2362541273.HKD","LU0289739699.SGD","REGN","HHS","LU2106854487.HKD","LU2089984988.USD"],"gpt_icon":0},{"id":"2568836285","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2568836285","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568836285?lang=en_us&edition=fundamental","pubTime":"2025-09-19 04:46","pubTimestamp":1758228360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 2.26% to $598.71 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.48% to 6,631.96 and the Dow Jones Industrial Average  rising 0.27% to 46,142.42.This was the stock's fourth consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 48.65% below its 52-week high of $1,165.85, which the company achieved on September 19th.The stock outperformed some of its competitors Thursday, as Amgen Inc.  rose 0.41% to $275.83, Moderna Inc.  rose 1.80% to $25.45, and Gilead Sciences Inc.  rose 1.21% to $113.62.Trading volume  eclipsed its 50-day average volume of 962,266.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Ne","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2568097494","title":"Regeneron's Potential Obesity Treatment Could Preserve Muscle Mass","url":"https://stock-news.laohu8.com/highlight/detail?id=2568097494","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568097494?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:15","pubTimestamp":1758118500,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals said a mid-stage study of its potential obesity treatment found that it could meaningfully preserve muscle mass while enhancing fat loss.The biotechnology company said Wednesday the combination of semaglutide, a weight-loss drug, and trevogrumab, a drug that preserves muscle mass, could significantly reduce the loss of lean mass associated with semaglutide-induced weight loss.Results from a recent Phase 2 trial confirmed that about one-third of weight loss induced by semaglutide was due to the loss of lean mass, and that adding trevogrumab could prevent about half of this lean mass loss.\"These encouraging early data, with positive trends in lipid parameters, warrant further studies to confirm the potential of trevogrumab's role in preserving lean muscle mass during weight loss,\" said Julio Rosenstock, director of the Dallas Diabetes Research Center at Medical City, and a clinical professor of medicine at the University of Texas Southwestern Medical Center, Dal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2362541513.USD","LU0320765992.SGD","LU2089984988.USD","REGN","LU0889565916.HKD","LU0053666078.USD","LU0109394709.USD","LU0058720904.USD","LU2023250504.SGD","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU2362541273.HKD","BK4139","BK4585","LU1974910355.USD","BK4588","LU0882574055.USD","LU1917777945.USD","LU2362540622.SGD","LU0823416689.USD","LU2237438978.USD","LU0823434583.USD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2568419494","title":"Regeneron Pharmaceuticals Shares up 1.4% After Rare Bone Disorder Drug Succeeds in Late-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2568419494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568419494?lang=en_us&edition=fundamental","pubTime":"2025-09-17 22:04","pubTimestamp":1758117886,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nFWN3V40KT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362541273.HKD","BK4588","LU2237438978.USD","REGN","LU0823416689.USD","LU0058720904.USD","LU1974910355.USD","LU2089984988.USD","LU2468319806.SGD","LU2362541513.USD","LU2106854487.HKD","LU0823434740.USD","LU2362540622.SGD","BK4585","BK4139","LU0053666078.USD","LU0114720955.EUR","LU2023250504.SGD","LU0109394709.USD","LU0289739699.SGD","LU0889565916.HKD","LU0823434583.USD","LU0320765992.SGD","LU0882574055.USD","LU1917777945.USD"],"gpt_icon":0},{"id":"2568912174","title":"Regeneron announces updated analyses from Phase 2 COURAGE trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2568912174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568912174?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:35","pubTimestamp":1758116146,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced updated analyses from the ongoing Phase 2 COURAGE trial investigating novel combinations of semaglutide ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-updated-analyses-from-phase-2-courage-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-updated-analyses-from-phase-2-courage-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2468319806.SGD","LU0320765992.SGD","LU0882574055.USD","LU1917777945.USD","LU1974910355.USD","LU2362540622.SGD","REGN","LU2023250504.SGD","LU2362541273.HKD","LU0058720904.USD","LU0053666078.USD","BK4588","BK4139","LU0114720955.EUR","LU2237438978.USD","LU0889565916.HKD","LU0823416689.USD","LU0823434583.USD","LU0823434740.USD","LU2089984988.USD","LU0289739699.SGD","LU2106854487.HKD","LU2362541513.USD","BK4585"],"gpt_icon":0},{"id":"2568491937","title":"Results From Phase 2 Courage Trial Demonstrating Potential to Improve Quality of Glp-1 Receptor Agonist-Induced Weight Loss by Preserving Lean Mass, Presented at Easd","url":"https://stock-news.laohu8.com/highlight/detail?id=2568491937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568491937?lang=en_us&edition=fundamental","pubTime":"2025-09-17 21:30","pubTimestamp":1758115800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA2RQXFR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053666078.USD","LU2362541513.USD","LU0889565916.HKD","LU1974910355.USD","LU2023250504.SGD","LU2237438978.USD","LU0289739699.SGD","LU2468319806.SGD","LU2362540622.SGD","BK4588","BK4585","LU0882574055.USD","LU0823416689.USD","BK4139","LU0058720904.USD","LU2362541273.HKD","REGN","LU0320765992.SGD","LU0823434740.USD","LU0109394709.USD","LU0114720955.EUR","LU1917777945.USD","LU0823434583.USD","LU2089984988.USD","LU2106854487.HKD"],"gpt_icon":0},{"id":"2568493493","title":"Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2568493493","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568493493?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:48","pubTimestamp":1758109693,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  said Wednesday its phase 3 study of garetosmab in adults with fibrodysplasia ossificans progressiva, or FOP, met its primary endpoint, demonstrating a greater reduction in new bone lesions compared with placebo.The company said the trial enrolled 63 people with FOP aged at least 18 years old. The primary and key secondary endpoints were assessed at 56 weeks, with results indicating a reduction in total new lesion volume with garetosmab, Regeneron added.Regeneron said it plans to complete the US regulatory submission for garetosmab in FOP by year-end, to be followed by global regulatory submissions in 2026. The company said it also expects to start a phase 3 trial of garetosmab in adolescents and children with FOP in 2026.Regeneron shares were fractionally higher in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN","LU0114720955.EUR","LU0889565916.HKD","LU0058720904.USD","LU0109394709.USD","LU2362541273.HKD","BK4585","LU0823434740.USD","LU1917777945.USD","BK4139","LU2106854487.HKD","LU2468319806.SGD","LU2237438978.USD","LU0289739699.SGD","LU0053666078.USD","LU0882574055.USD","LU1974910355.USD","LU2362541513.USD","LU0320765992.SGD","LU0823416689.USD","BK4588","LU2023250504.SGD","LU2089984988.USD","LU2362540622.SGD","LU0823434583.USD"],"gpt_icon":0},{"id":"2568982314","title":"Regeneron announces primary endpoint met in Phase 3 OPTIMA trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2568982314","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568982314?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:10","pubTimestamp":1758107434,"startTime":"0","endTime":"0","summary":"Regeneron (REGN) Pharmaceuticals announced the primary endpoint was met in the Phase 3 OPTIMA trial investigating garetosmab in adults with fibrody...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regeneron-announces-primary-endpoint-met-in-phase-3-optima-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regeneron-announces-primary-endpoint-met-in-phase-3-optima-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN","LU0114720955.EUR","LU0889565916.HKD","LU0058720904.USD","LU0109394709.USD","LU2362541273.HKD","BK4585","LU0823434740.USD","LU1917777945.USD","BK4139","LU2106854487.HKD","LU2468319806.SGD","LU2237438978.USD","LU0289739699.SGD","LU0053666078.USD","LU0882574055.USD","LU1974910355.USD","LU2362541513.USD","LU0320765992.SGD","LU0823416689.USD","BK4588","LU2023250504.SGD","LU2089984988.USD","LU2362540622.SGD","LU0823434583.USD"],"gpt_icon":0},{"id":"2568460763","title":"Regeneron Pharmaceuticals Inc - Garetosmab Shows 90% Reduction in New Ho Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2568460763","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568460763?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA1GBRYL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362541513.USD","LU2362540622.SGD","LU0289739699.SGD","LU0053666078.USD","LU2106854487.HKD","LU0889565916.HKD","BK4588","LU0823434740.USD","REGN","LU1917777945.USD","LU0823416689.USD","LU2468319806.SGD","BK4139","BK4585","LU0109394709.USD","LU2237438978.USD","LU0114720955.EUR","LU1974910355.USD","LU0320765992.SGD","LU2023250504.SGD","LU0058720904.USD","LU2089984988.USD","LU2362541273.HKD","LU0882574055.USD","LU0823434583.USD"],"gpt_icon":0},{"id":"2568460757","title":"Regeneron Pharmaceuticals Inc - U.S. Regulatory Submission for Garetosmab Planned for Year-End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2568460757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568460757?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA1GBRYL:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","LU2089984988.USD","BK4588","LU1974910355.USD","LU2023250504.SGD","LU0289739699.SGD","LU1917777945.USD","LU0823416689.USD","LU0823434583.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541513.USD","LU2362541273.HKD","LU0823434740.USD","LU0114720955.EUR","BK4139","LU2362540622.SGD","LU2468319806.SGD","LU0889565916.HKD","LU0882574055.USD","BK4585","LU0109394709.USD","REGN"],"gpt_icon":0},{"id":"2568460751","title":"Regeneron Pharmaceuticals Inc - Announces Primary Endpoint Met in Phase 3 Fop Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2568460751","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568460751?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA1GBRYL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237438978.USD","LU2362541513.USD","LU0058720904.USD","BK4139","LU0823434740.USD","LU2106854487.HKD","LU2362540622.SGD","LU2362541273.HKD","LU2468319806.SGD","BK4588","LU0053666078.USD","LU0114720955.EUR","LU0823434583.USD","LU0289739699.SGD","LU2089984988.USD","LU0320765992.SGD","LU2023250504.SGD","LU1917777945.USD","LU0882574055.USD","LU1974910355.USD","LU0889565916.HKD","REGN","LU0109394709.USD","LU0823416689.USD","BK4585"],"gpt_icon":0},{"id":"2568460710","title":"Regeneron Pharmaceuticals Inc - Garetosmab Shows 94% and 90% Reduction in New Bone Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2568460710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568460710?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA1GBRYL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0114720955.EUR","LU0109394709.USD","LU0823434740.USD","LU2023250504.SGD","BK4139","LU0823416689.USD","LU0882574055.USD","LU2362541273.HKD","LU0058720904.USD","REGN","LU0823434583.USD","LU1974910355.USD","BK4585","LU0053666078.USD","LU2362540622.SGD","LU2362541513.USD","LU2089984988.USD","LU0889565916.HKD","LU2106854487.HKD","LU2468319806.SGD","LU0289739699.SGD","LU0320765992.SGD","BK4588","LU2237438978.USD","LU1917777945.USD"],"gpt_icon":0},{"id":"2568349835","title":"Regeneron Announces Positive Phase 3 Trial in Adults with Ultra-Rare Genetic Disorder Fibrodysplasia Ossificans Progressiva (FOP), Demonstrating that Garetosmab Prevents Greater than 99% of Abnormal Bone Formation","url":"https://stock-news.laohu8.com/highlight/detail?id=2568349835","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568349835?lang=en_us&edition=fundamental","pubTime":"2025-09-17 19:00","pubTimestamp":1758106800,"startTime":"0","endTime":"0","summary":"FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab is the first and only treatment to demonstrate a dramatic red","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/17/3151506/0/en/Regeneron-Announces-Positive-Phase-3-Trial-in-Adults-with-Ultra-Rare-Genetic-Disorder-Fibrodysplasia-Ossificans-Progressiva-FOP-Demonstrating-that-Garetosmab-Prevents-Greater-than-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","REGN","BK4156","LU2362540622.SGD","BK4139","LU2468319806.SGD","LU0109394709.USD","LU0882574055.USD","LU0053666078.USD","LU0058720904.USD","BK4585","LU0289739699.SGD","LU1917777945.USD","LU0823434740.USD","BK4588","LU2023250504.SGD","LU2089984988.USD","LU2362541513.USD","LU0823416689.USD","LU0889565916.HKD","LU2106854487.HKD","LU0320765992.SGD","LU1974910355.USD","LU0114720955.EUR","LU0823434583.USD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2567147752","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2567147752","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567147752?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:47","pubTimestamp":1757969220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rose 2.25% to $572.59 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.47% to 6,615.28 and the Dow Jones Industrial Average  rising 0.11% to 45,883.45.Regeneron Pharmaceuticals Inc. closed 50.89% below its 52-week high of $1,165.85, which the company reached on September 19th.The stock outperformed some of its competitors Monday, as Amgen Inc.  fell 0.72% to $274.40, Moderna Inc.  rose 1.57% to $23.88, and Gilead Sciences Inc.  fell 1.07% to $112.54.Trading volume  eclipsed its 50-day average volume of 955,032.Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2567136592","title":"Does Regeneron Offer Value After Shares Slide 21.7% Year to Date in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136592","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567136592?lang=en_us&edition=fundamental","pubTime":"2025-09-14 02:24","pubTimestamp":1757787866,"startTime":"0","endTime":"0","summary":"If you have ever wondered whether now is the right time to buy, hold, or reconsider Regeneron Pharmaceuticals, you are definitely not alone. The company has been on quite a ride, with shares recently closing at $560. Quick glances at the stock chart show a stark contrast between short-term and long-term moves, with the price down 2.3% over the past week, and only slightly lower at 0.3% for the last month. However, the picture becomes far more dramatic if you zoom out: year to date,...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/does-regeneron-offer-value-after-shares-slide-217-year-to-da","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/does-regeneron-offer-value-after-shares-slide-217-year-to-da","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","LU2237438978.USD","BK4139","LU0114720955.EUR","LU0823416689.USD","LU0882574055.USD","LU2362540622.SGD","LU2089984988.USD","LU1917777945.USD","LU2468319806.SGD","LU1974910355.USD","BK4585","DCF","LU0823434583.USD","REGN","LU0109394709.USD","LU2362541273.HKD","LU0289739699.SGD","LU2106854487.HKD","LU0889565916.HKD","LU0823434740.USD","LU0053666078.USD","LU0058720904.USD","LU2023250504.SGD","BK4588","LU2362541513.USD"],"gpt_icon":0},{"id":"2567904458","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2567904458","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567904458?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:47","pubTimestamp":1757710020,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  slid 1.44% to $560.00 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.05% to 6,584.29 and Dow Jones Industrial Average  falling 0.59% to 45,834.22.Regeneron Pharmaceuticals Inc. closed 52.16% below its 52-week high of $1,170.58, which the company achieved on September 13th.Despite its losses, the stock outperformed some of its competitors Friday, as Amgen Inc.  fell 2.24% to $276.39, Moderna Inc.  fell 7.40% to $23.51, and Gilead Sciences Inc.  fell 2.81% to $114.55.Trading volume  remained 356,909 below its 50-day average volume of 959,340.Data source: Dow Jones Market Data, FactSet. Data compiled September 12, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":177,"code":"91000000","status":"200"}]}}